TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, bought 5,000 shares of the business’s stock in a transaction that occurred on Friday, May 27th. The shares were acquired at an average price of $7.43 per share, with a total value of $37,150.00. Following the completion of the transaction, the insider […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, purchased 5,000 shares of the stock in a transaction that occurred on Wednesday, May 25th. The shares were purchased at an average price of $6.87 per share, for a total transaction of $34,350.00. Following the completion of the purchase, the insider now […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, acquired 5,000 shares of TELA Bio stock in a transaction that occurred on Monday, May 23rd. The shares were purchased at an average cost of $8.53 per share, for a total transaction of $42,650.00. Following the purchase, the insider now directly owns […]
TELA Bio, Inc. (NASDAQ:TELA – Get Rating) insider Ew Healthcare Partners Fund 2, bought 5,000 shares of the stock in a transaction on Friday, May 20th. The shares were acquired at an average cost of $8.79 per share, with a total value of $43,950.00. Following the purchase, the insider now owns 3,430,709 shares of the […]
TELA Bio (NASDAQ:TELA – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday, Zacks.com reports. According to Zacks, “TELA Bio Inc. is a commercial stage medical technology company. It is focused on the designing, developing and marketing of tissue reinforcement materials […]